About Us

Luye Pharma Group (02186.HK), a member of Luye Life Sciences Group, is an international pharmaceutical company dedicated to the R&D, manufacturing and sale of innovative medications.

Luye Pharma Will Receive RMB 1.6 Billion Strategic Investment for Shenzhen Luye

News

Shanghai, July 23, 2024 -- Luye Pharma Group has announced that its subsidiary, Shenzhen Luye, will receive a strategic investment of up to RMB 1.6 billion from Shenzhen Luye Private Equity Investment Fund. Nanjing Luye, a wholly-owned ...

July 23,2024

Luye Pharma’s Analgesic Drug Mimeixin (Oxycodone Hydrochloride and Naloxone Hydrochloride Sustained-Release Tablets) Approved for Marketing in ...

Shanghai, July 4, 2024 — Luye Pharma Group announced that its Mimeixin (oxycodone hydrochloride and naloxone hydrochloride sustained-release tablets) was approved for marketing by China's National Medical Products Administration ...

July 04,2024

Read More

Investors

Employee Stories

Upholding the philosophy of “Employee Development”,
Luye Pharma regards employees as the most valuable resources of the company